Global Breakthrough: FGC2.3 Feline Vocalization Project Nears Record Reads — Over 14,000 Scientists Engage With Cat-Human Translation Research

Global Breakthrough: FGC2.3 Feline Vocalization Project Nears Record Reads — Over 14,000 Scientists Engage With Cat-Human Translation Research

MIAMI, FL — The FGC2.3: Feline Vocalization Classification and Cat Translation Project, authored by Dr. Vladislav Reznikov, has crossed a critical scientific milestone — surpassing 14,000 reads on ResearchGate and rapidly climbing toward record-setting levels in the field of animal communication and artificial intelligence. This pioneering work aims to develop the world’s first scientifically grounded…

Tariff-Free Relocation to the US

Tariff-Free Relocation to the US

EU, China, and more are now in the crosshairs. How’s next? It’s time to act. The Trump administration has announced sweeping tariff hikes, as high as 50%, on imports from the European Union, China, and other major markets. Affected industries? Pharmaceuticals, Biotech, Medical Devices, IVD, and Food Supplements — core sectors now facing crippling costs,…

Global Distribution of the NRAs Maturity Levels as of the WHO Global Benchmarking Tool and the ICH data

Global Distribution of the NRAs Maturity Levels as of the WHO Global Benchmarking Tool and the ICH data

This study presents the GDP Matrix by Dr. Vlad Reznikov, a bubble chart designed to clarify the complex relationships between GDP, PPP, and population data by categorizing countries into four quadrants—ROCKSTARS, HONEYBEES, MAVERICKS, and UNDERDOGS depending on National Regulatory Authorities (NRAs) Maturity Level (ML) of the regulatory affairs requirements for healthcare products. Find more details…

Crucial Update: Significant News to Share

Dear readers,

We would like to share some important news with you.

After years of bringing you the latest insights, analysis and innovation news from the pharma industries, we have made the difficult decision to close Outsourcing Pharma and BioPharma Reporter.

It has been our privilege to serve as your trusted source of information about the industry.

Your engagement, feedback and support have fuelled our mission to inform, inspire, and connect professionals in this dynamic field.

As the industry evolves, so too must William Reed. While our pharma sites will no longer be active, we will be turning our focus to our NutraIngredients, FoodNavigator (and sister food
sites, DairyReporter, ConfectioneryNews, BeverageDaily and Bakery&Snacks), CosmeticsDesign, and AgTechNavigator titles.

To our valued contributors and readers: a heartfelt thank you for being an integral part of our journey. Your engagement has enriched our content and helped us build a community of
professionals dedicated to innovation and excellence. We hope that the insights you have gained here will continue to inform your work and inspire
your future endeavors.

Thank you once again for your support. We look forward to crossing paths again in the future.

The BioPharma Reporter team

AI Discovers Unseen Principles of Cellular Interior Design

AI Discovers Unseen Principles of Cellular Interior Design

A new deep-learning model can now predict how proteins sort themselves inside the cell. The model has uncovered a hidden layer of molecular code that shapes biological organization, adding new dimensions of complexity to our understanding of life and offering a powerful biotechnology tool for drug design and discovery.

Previous AI systems in biology, such as the Nobel Prize-winning AlphaFold, have focused on predicting protein structure. But this new system, dubbed ProtGPS, allows scientists to predict not just how a protein is built, but where it belongs inside the cell. It also empowers scientists to engineer proteins with defined distributions, directing them to cellular locations with surgical precision.

“Knowledge of where a protein goes is entirely complementary to how it folds,” says Henry Kilgore, a chemical biologist at the Whitehead Institute for Biomedical Research in Cambridge, Mass., who co-led the research. Together, these properties shape its function and interactions within the cell. These insights—and the machine learning tools that make them possible—“will come to have a substantial impact on drug development programs,” he says.

Kilgore and his colleagues described the new tool in a paper published 6 February in the journal Science.

Putting Proteins on the Cellular Map

Over the past few years, AI tools like AlphaFold have revolutionized structural biology by predicting protein shapes—much like the instruction manual that comes with a piece of IKEA furniture, showing how to assemble the chair or bed. But it turns out knowing a protein’s structure isn’t enough to understand its function. ProtGPS fills in this missing piece by determining where each molecular piece of “furniture” belongs within the cell’s open-plan interior.

Some proteins have clear destinations. Researchers have known for decades that proteins headed for places like the nucleus or mitochondriastructures enclosed by membranes and walled off from the rest of the cellcarry short signaling tags that guide them.

But much of the cell is an open environment, where proteins rely on more subtle cues to sort themselves into what are called biomolecular condensates—dynamic, liquid-like clusters that help regulate gene activity, manage cellular stress, and contribute to disease. And just as a cozy armchair might naturally fit into a reading nook, proteins follow intrinsic molecular placement rules that guide them to specialized condensates suited to particular functions.

ProtGPS has now begun to decode these rules, uncovering hidden features in the sequence of amino acids that form the backbone of all proteins—intrinsic sorting cues that determine whether and where a protein will localize within different condensates in the cell.

“Our model is learning these localization features,” says co-author Itamar Chinn, a machine-learning scientist at MIT. “And we can use those features to make new proteins that have the localization we want.”

Prot GPS development schematic. Learned representation of E SM2 proteins, and protein sequences annotated by distribution, yield protein representation of condensate departments. The compartment probability, which includes P-body, stress granule, and more, results in a fine-tuned model for predicting condensate compartment.
ProtGPS uses a machine-learning framework to predict protein localization within condensate compartments.Henry R. Kilgore et al./Science

Teaching AI the Language of Proteins

ProtGPS is what’s known as a protein language model. It works much like LLMs such as OpenAI’s ChatGPT or Anthropic’s Claude, predicting sequences based on learned patterns. But instead of processing text or speech, ProtGPS analyzes proteins, which are represented as strings of letters, each corresponding to one of 20 amino acid building blocks—L for leucine, S for serine, and so on.

Kilgore, Chinn, and their colleagues built the model using a deep-learning framework called ESM, originally developed by Meta for predicting protein structures, functions, and properties.

Short for Evolutionary Scale Modeling, ESM—like AlphaFold—also extracts meaningful patterns from protein sequences. But instead of using physics to predict precise atomic-level structures, as AlphaFold does, Meta’s model relies on sequence-based learning without complex 3D calculations, making it substantially faster and more scalable for analyzing large datasets. (An upgraded version of ESM with improved capabilities was unveiled last month.)

Kilgore and Chinn’s team used ESM’s architecture to decode cryptic signals embedded in the amino acid sequences. The researchers adapted and refined the tool to both predict where proteins assemble and to enable the design of new kinds of proteins—ones that do not exist in nature, but can be engineered with precise condensate-targeting properties.

Thus, ProtGPS was born. The researchers trained the model on nearly 5,000 human proteins known to localize to one of 12 different condensate compartments. They then tested ProtGPS on an independent dataset, finding that it could accurately place proteins in the correct part of the cell.

An Elusive Code of Compartmentalization

Certain physical and chemical traits, like the charge and water-repelling nature of a protein, seemed to play a role in where things end up in the cell. But, as is often the case with machine-learning models, the exact reasoning behind ProtGPS’s predictions—and, by extension, the biology behind the selective distribution—remain largely a mystery.

That’s not to say the researchers didn’t try to tease it apart. They combed through the model’s predictions, searching for clear sequence patterns or biochemical properties that might explain its sorting rules. “Nothing obvious really falls out,” says co-author Peter Mikhael, a computational biologist at MIT.

That black box opacity is a familiar challenge in AI. Language models, by their very nature, excel at bringing together contributions from many different features and contextual signals, allowing them to detect patterns that aren’t immediately obvious to humans. “So, it’s not all that surprising” that ProtGPS can extract localization cues that even experienced biologists struggle to define, says Ilan Mitnikov, a machine-learning scientist formerly at MIT who helped to develop the model.

“If the rules were simple, people would have already figured them out,” Mitnikov says.

Engineering Proteins, Predicting Diseases

Even without a full understanding of what governs a protein’s cellular destination, the researchers showed that ProtGPS could be used to create proteins with carefully tuned localization properties. The tool also proved capable of predicting how mutations linked to disease might disrupt protein compartmentalization, shedding light on the molecular mechanisms underlying conditions such as cancer and developmental disorders.

Dewpoint Therapeutics—a biotech company co-founded by one of the study’s authors, Whitehead biologist Richard Young—now plans to integrate ProtGPS into its drug discovery efforts, according to chief scientific officer Isaac Klein, who called the tool a “game-changer” for identifying drug targets and designing new therapies. (Young, Kilgore, and MIT computer scientist Regina Barzilay, who also helped lead the study, all hold consulting or advisory roles with Dewpoint.)

Other scientists also see potential for the tool, including Tuomas Knowles, a biophysicist at the University of Cambridge who serves as chief technology officer of Transition Bio, another company focused on drug discovery against condensate targets. “What is particularly exciting is that this paper provides further evidence that there are very specific sequence features that govern localization and partitioning of proteins into condensates in living cells,” says Knowles, who was not involved in the research. “Furthermore, this provides new opportunities to influence and control protein localization—and potentially correct mis-localization, which is at the origin of many diseases,” he adds.

But beyond its applied utility, ProtGPS highlights an emerging paradigm in biology, in which the physical arrangement of the molecules within a cell is as critical to its function as the molecules’ structure, with codes embedded in the amino sequence that impact folding and cellular compartmentalization alike.

Just as a well-designed home is more than a collection of furniture—it relies on intuitive placement to maximize utility—cells, too, require precise molecular organization to function optimally. By uncovering hidden patterns in protein sequences, ProtGPS may serve as the architect of this cellular flow, decoding nature’s blueprint for the cell’s interior design.

Introducing the Latest IEEE Standard for Enhancing Security in Biomedical Devices and Data

Introducing the Latest IEEE Standard for Enhancing Security in Biomedical Devices and Data

If you have an implanted medical device, have been hooked up to a machine in a hospital, or have accessed your electronic medical records, you might assume the infrastructure and data are secure and protected against hackers. That isn’t necessarily the case, though. Connected medical devices and systems are vulnerable to cyberattacks, which could reveal sensitive data, delay critical care, and physically harm patients.

The U.S. Food and Drug Administration, which oversees the safety and effectiveness of medical equipment sold in the country, has recalled medical devices in the past few years due to cybersecurity concerns. They include pacemakers, DNA sequencing instruments, and insulin pumps.

In addition, hundreds of medical facilities have experienced ransomware attacks, in which malicious people encrypt a hospital’s computer systems and data and then demand a hefty ransom to restore access. Tedros Adhanom Ghebreyesus, the World Health Organization’s director-general, warned the U.N. Security Council in November about the “devastating effects of ransomware and cyberattacks on health infrastructure.”

To help better secure medical devices, equipment, and systems against cyberattacks, IEEE has partnered with Underwriters Laboratories, which tests and certifies products, to develop IEEE/UL 2933, Standard for Clinical Internet of Things (IoT) Data and Device Interoperability with TIPPSS (Trust, Identity, Privacy, Protection, Safety, and Security).

“Because most connected systems use common off-the-shelf components, everything is now hackable, including medical devices and their networks,” says Florence Hudson, chair of the IEEE 2933 Working Group. “That’s the problem this standard is solving.”

Hudson, an IEEE senior member, is executive director of the Northeast Big Data Innovation Hub at Columbia. She is also founder and CEO of cybersecurity consulting firm FDHint, also in New York.

A framework for strengthening security

Released in September, IEEE 2933 covers ways to secure electronic health records, electronic medical records, and in-hospital and wearable devices that communicate with each other and with other health care systems. TIPPSS is a framework that addresses the different security aspects of the devices and systems.

“If you hack an implanted medical device, you can immediately kill a human. Some implanted devices, for example, can be hacked within 15 meters of the user,” Hudson says. “From discussions with various health care providers over the years, this standard is long overdue.”

More than 300 people from 32 countries helped develop the IEEE 2933 standard. The working group included representatives from health care–related organizations including Draeger Medical Systems, Indiana University Health, Medtronic, and Thermo Fisher Scientific. The FDA and other regulatory agencies participated as well. In addition, there were representatives from research institutes including Columbia, European University Cyprus, the Jožef Stefan Institute, and Kingston University London.

“Because most connected systems use common off-the-shelf components, everything is now hackable, including medical devices and their networks.”

The working group received an IEEE Standards Association Emerging Technology Award last year for its efforts.

IEEE 2933 was sponsored by the IEEE Engineering in Medicine and Biology Society because, Hudson says, “it’s the engineers who have to worry about ways to protect the equipment.”

She says the standard is intended for the entire health care industry, including medical device manufacturers; hardware, software, and firmware developers; patients; care providers; and regulatory agencies.

Six security measures to reduce cyberthreats

Hudson says that security in the design of hardware, firmware, and software needs to be the first step in the development process. That’s where TIPPSS comes in.

“It provides a framework that includes technical recommendations and best practices for connected health care data, devices, and humans,” she says.

TIPPSS focuses on the following six areas to secure the devices and systems covered in the standard.

  • Trust. Establish reliable and trustworthy connections among devices. Allow only designated devices, people, and services to have access.
  • Identity. Ensure that devices and users are correctly identified and authenticated. Validate the identity of people, services, and things.
  • Privacy. Protect sensitive patient data from unauthorized access.
  • Protection. Implement measures to safeguard devices from cyberthreats and protect them and their users from physical, digital, financial, and reputational harm.
  • Safety. Ensure that devices operate safely and do not pose risks to patients.
  • Security. Maintain the overall security of the device, data, and patients.

TIPPSS includes technical recommendations such as multifactor authentication; encryption at the hardware, software, and firmware levels; and encryption of data when at rest or in motion, Hudson says.

In an insulin pump, for example, data at rest is when the pump is gathering information about a patient’s glucose level. Data in motion travels to the actuator, which controls how much insulin to give and when it continues to the physician’s system and, ultimately, is entered into the patient’s electronic records.

“The framework includes all these different pieces and processes to keep the data, devices, and humans safer,” Hudson says.

Four use cases

Included in the standard are four scenarios that outline the steps users of the standard would take to ensure that the medical equipment they interact with is trustworthy in multiple environments. The use cases include a continuous glucose monitor (CGM), an automated insulin delivery (AID) system, and hospital-at-home and home-to-hospital scenarios. They include devices that travel with the patient, such as CGM and AID systems, as well as devices a patient uses at home, as well as pacemakers, oxygen sensors, cardiac monitors, and other tools that must connect to an in-hospital environment.

The standard is available for purchase from IEEE and UL (UL2933:2024).

On-demand videos on TIPPSS cybersecurity

IEEE has held a series of TIPPSS framework workshops, now available on demand. They include IEEE Cybersecurity TIPPSS for Industry and Securing IoTs for Remote Subject Monitoring in Clinical Trials. There are also on-demand videos about protecting health care systems, including the Global Connected Healthcare Cybersecurity Workshop Series, Data and Device Identity, Validation, and Interoperability in Connected Healthcare, and Privacy, Ethics, and Trust in Connected Healthcare.

IEEE SA offers a conformity assessment tool, the IEEE Medical Device Cybersecurity Certification Program. The straightforward evaluation process has a clear definition of scope and test requirements specific to medical devices for assessment against the IEEE 2621 test plan, which helps manage cybersecurity vulnerabilities in medical devices.

Discovering New Aspects of Magnetism Through Google’s Quantum Simulator

Discovering New Aspects of Magnetism Through Google’s Quantum Simulator

When Nobel laureate Richard Feynman first suggested the idea of quantum computers, he proposed they might perform the kind of complex quantum simulations that may yield insights into next-generation batteries or novel drugs. Now a new quantum simulator from Google has discovered that magnetism does not always work the way scientists think, suggesting that it has promise for unearthing more discoveries in the future.

The new research combines two kinds of quantum computing—analog and digital. In analog quantum computing, qubits can serve as analogues of other objects that display quantum behavior, such as molecules, atoms, and subatomic particles. Analog quantum computing is often used to simulate molecular interactions that are too complex for any classical computer to model within our lifetimes.

In contrast, digital quantum computers run sequences of elementary operations, called quantum logic gates, on a set of qubits. With enough qubits, a quantum computer could theoretically vastly outperform all classical computers on a number of applications. For instance, on quantum computers, Shor’s algorithm can crack modern cryptography, and Grover’s algorithm can search databases at staggering speeds.

Digital quantum computers can perform quantum simulations, but analog quantum computers are faster at this task. For instance, when simulating how three atoms might interact, a digital quantum computer would have to model the interactions between each combination of atoms one step at a time, whereas an analog quantum computer could model them all simultaneously. Speed is especially important, given the current error-prone nature of quantum hardware—the faster the operation, the more likely it will be successfully completed.

Still, digital quantum computers are more flexible at quantum simulation than analog quantum computers are. Analog quantum computers are designed to mimic whatever they are simulating as closely as possible, whereas digital quantum computers are more tunable in what they can simulate.

Google’s Analog-Digital Hybrid Quantum Simulation

Now Google “is launching a new analog-digital hybrid approach for quantum simulation to try and get the best of both worlds,” says Trond Andersen, a senior research scientist at Google Quantum AI in Mountain View, Calif. The researchers detailed their findings online 5 February in the journal Nature.

The new system possesses 69 superconducting qubits. It begins its simulations by applying gates to qubits to prepare the initial states of the model, and then lets the model quickly evolve in an analog manner. Finally, it returns to digital performance so that researchers can measure the results in an extensive way. “We get a combination of flexibility and speed,” Andersen says.

Previous research had explored analog-digital hybrid quantum simulation, but it often suffered from large errors during the analog evolution stage. The new system employed a high-fidelity calibration scheme that significantly reduced this problem, achieving a 0.1 percent error rate per qubit. “This was one of the breakthroughs that made this work possible,” Andersen says.

In benchmarking experiments, the scientists estimated that simulations with the level of fidelity seen with the new system would require more than 1 million years on the Frontier supercomputer at Oak Ridge National Laboratory, in Tennessee. “We’re excited about our new direction for discoveries and applications that we could not achieve on a classical computer,” Andersen says.

Moreover, the new simulator made an unexpected discovery. It found out that the widely used Kibble-Zurek mechanism—which can, for instance, predict the behavior of magnets during phase transitions—does not always hold.

“This was a big surprise—this is a mechanism very widely studied in quantum labs all over the world,” Andersen says. Understanding the dynamics associated with the Kibble-Zurek mechanism “is important for various types of quantum simulation.” he says.

Andersen notes that this discovery could have been made with a classical computer. “We’re now starting to use our approach for applications that would be impossible with a classical computer,” he says. This research was conducted with Google’s Sycamore quantum processors, and Andersen says the company “now has a new, advanced chip, Willow, that we are excited to try our approach on.”

X4 Pharmaceuticals Faces Setbacks, Reducing Staff by 30%

X4 Pharmaceuticals Faces Setbacks, Reducing Staff by 30%

The headcount reduction will save money that the company will use in developing mavorixafor, its CXCR4 antagonist that last year received FDA approval to treat WHIM syndrome, in the larger patient population with chronic neutropenia.